NovaBay Pharma rises on marketing boost for facial sanitizer

Stablecoin Development

24/09/2020 13:08

** Biopharma co's shares  NBY.A  rise 4.5% to 77 cents
premarket 
    ** Co says it is expanding consumer marketing of its facial
sanitizer Avenova, by partnering with PartnerCentric Inc and HVM
Communications to generate greater awareness and promote online
sales  urn:newsml:reuters.com:*:nBw2jdnVwa
    ** Avenova has been used since 2015 for eyelid and eyelash
cleansing and is FDA-cleared
    ** Co said in July tests carried out by an independent
third-party lab confirmed that Avenova killed SARS-CoV-2, which
causes COVID-19, on hard surfaces  urn:newsml:reuters.com:*:nL3N2EK2KR
    ** Up to Wednesday's close, stock had risen ~16% YTD 

 (Reporting by Dania Nadeem in Bengaluru)
 ((Dania.Nadeem@thomsonreuters.com; within U.S. +1 646 223 8780,
outside U.S. +91 80 6182 3463;))